表紙
市場調查報告書
商品編碼
1070882

顱內動脈瘤市場-市場洞察、競爭條件、市場預測:2027 年

Intracranial Aneurysms- Market Insights, Competitive Landscape and Market Forecast-2027

出版日期: 按訂單生產 | 出版商: DelveInsight Business Research LLP | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2021 年全球顱內動脈瘤市場規模達到 11.3 億美元。在 2022 年至 2027 年的預測期內,該市場預計將以 9.10% 的複合年增長率增長,到 2027 年達到 19 億美元。

本報告探討了顱內動脈瘤市場,概述了市場、按產品類型、最終用戶、地區和進入市場的公司概況劃分的趨勢。

目錄

第 1 章顱內動脈瘤市場報告介紹

第 2 章顱內動脈瘤市場執行摘要

第三章監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章顱內動脈瘤市場主要因素分析

  • 推動顱內動脈瘤市場的因素
    • 由於嚴重的頭部外傷、久坐不動的生活方式等,腦動脈瘤和動靜脈畸形 (AVM) 的患病率增加。
    • 全球高血壓患病率增加
    • 產品在全球範圍內獲得批准和發布
    • 老年人口不斷擴大
  • 顱內動脈瘤市場的抑制因素和挑戰
    • 嚴格的監管審批流程
    • 顱內動脈瘤治療裝置相關並發症
  • 顱內動脈瘤市場機遇
    • 中低收入國家為顱內動脈瘤市場帶來巨大機遇
    • 全球和區域製造商的戰略性商業活動為市場帶來機遇

第5章顱內動脈瘤市場的波特五力分析

  • 賣方的議價能力
  • 買方的議價能力
  • 新進入者的威脅
  • 替代威脅
  • 競爭對手之間的敵對關係

第6章COVID-19對顱內動脈瘤市場影響分析

第7章顱內動脈瘤市場佈局

  • 按產品類型
    • 手術夾閉
    • 栓塞線圈
    • 分流器
    • 其他
  • 最終用戶
    • 醫院
    • 門診手術中心
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第8章全球顱內動脈瘤市場企業份額分析-3-5大公司

第 9 章顱內動脈瘤公司和產品簡介

  • Medtronic
  • MicroPort Scientific Corporation.
  • B. Braun Melsungen AG
  • Stryker
  • Johnson & Johnson Services, Inc.
  • Terumo Corporation
  • Penumbra, Inc
  • Balt
  • Wallaby Medical
  • Shape Memory Medical Inc
  • Zylox-Tonbridge Medical Technology Co., Ltd
  • Spartan Micro, Inc.
  • Mizuho Medical Co.Ltd
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • Phenox GmbH
  • Peter LAZIC GmbH
  • adeor Medical AG
  • Boston Scientific Corporation
  • Meril Life Sciences Pvt. Ltd
  • KANEKA CORPORATION

第10章KOL的觀點

第11章項目方法

第 12 章關於 DelveInsight

第13章免責聲明和查詢

目錄
Product Code: DIMDCL0525

Title:
Intracranial Aneurysms
Market By Product Type (Surgical Clipping, Embolization Coils, Flow Diverters, Others), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is projected to grow at a significant CAGR forecast till 2027 owing to the rising burden of brain aneurysms among the population across the globe and increase in launch of intracranial treatment product.

The global intracranial aneurysms market was valued at USD 1.13 billion in 2021, growing at a CAGR of 9.10% during the forecast period from 2022 to 2027, to reach USD 1.90 billion by 2027. The rise in the market for intracranial aneurysms is primarily due to the rising prevalence of abnormalities in blood vessels present in the brain, counting brain aneurysms and arteriovenous malformations (AVMs) owing to sedentary lifestyles. Furthermore, an increase in high blood pressure among the population, approval, and launch of various intracranial aneurysm treatment devices, and rising research and development activities for the development of intracranial aneurysm treatment devices, among others are anticipated to bolster the global intracranial aneurysm market.

Intracranial Aneurysms Market Dynamics:

The market for intracranial aneurysms is gaining momentum at present owing to the growing burden of brain aneurysms among the population. According to many pieces of research, there are various factors such as smoking, severe head injury, cocaine abuse, and an increase in blood pressure, among others that could increase the risk of developing brain aneurysms among the population. For instance, according to the statistics published by the World Health Organization (WHO) in the year 2021, an estimated 1.28 billion adults aged between 30-79 years have hypertension across the globe. The data also mentioned that two-thirds of the population suffering from hypertension are living in low- and middle-income countries. Thus, rising hypertension among the worldwide population could lead to an increased demand for aneurysm treatment devices during the forthcoming years.

In addition, the rising approval of products for the treatment of intracranial aneurysms is also a key factor responsible for the overall intracranial aneurysm market growth in the upcoming years. For instance, in July 2020, Balt secured CE Mark approval for its Silk Vista flow diverting stent to treat patients with intracranial aneurysms (unruptured), enabling commercialization in over 30 countries in and around the European Union.

Furthermore, the rapidly growing old age population is also likely to contribute to the intracranial aneurysm market as brain aneurysms are more common in adults between the ages of 30 and 60. According to the World Population Ageing 2020 Highlights, there were an estimated 727 million persons aged 65 years and above across the globe in the year 2020.

Hence, the interplay of all the aforementioned factors is anticipated to bolster the demand for neurovascular embolization devices during the forecasted period.

However, the stringent regulatory approval process of the intracranial aneurysm treatment devices and complications associated with devices is likely to impede the market growth.

Also, the COVID-19 pandemic had seriously affected the worldwide healthcare system. The system was transitioned at very short notice to deal with the burden of the pandemic, meaning that other health issues were unavoidably side-lined. Moreover, the implementation of lockdown, the social distancing norms, and containment measures in several countries along with halt in various surgeries have slowed down the market for intracranial aneurysms.

Intracranial Aneurysms Market Segment Analysis:

Intracranial Aneurysms Market By Product Type (Surgical Clipping, Embolization Coils, Flow Diverters, Others), By End-User (Hospitals and Ambulatory Surgical Centers), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the intracranial aneurysms product type segment, the embolization coils segment is expected to hold a noteworthy market share during the forecasted period. This is owing to the availability of various embolization coils in the market. In addition, increasing initiatives from the manufacturers' active in developing advanced embolization devices would also raise the adoption of these devices for intracranial aneurysm treatment thereby bolstering the segment market. For instance, in October 2019, TrelliX® Embolic Coil System which features proprietary shape memory polymer (SMP) technology was granted with CE Mark.

Also, in September 2019, Wallaby Medical received FDA 510(k) clearance and CE mark approval for the Avenir Coil System, its differentiated embolic coil system intended to use for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The system offers a full line of coils including exceptional stable framing coils, the extra volume filling coils, and ultra-soft finishing coils.

Furthermore, companies raising funds for the development and commercialization of the development of embolic coils are also expected to contribute to the segmental growth of the intracranial aneurysm market. For instance, in July 2021, a neuro- and peripheral-vascular interventional medical device company, Zylox-Tonbridge Medical Technology Co., Ltd. raised USD 329 million to aid the development and commercialization of its core products that include neurovascular embolization coils, a microcatheter for coiling, among others.

Hence, the interplay of all the aforementioned factors is projected to bolster the demand for embolization coils in the upcoming years.

North America is expected to dominate the overall Intracranial Aneurysms Market:

Among all the regions, North America is expected to occupy a major share in the overall Intracranial Aneurysms market during the forecasted period. This domination is because of the exponentially rising prevalence of the target population in the region. Furthermore, the recent launch of intracranial aneurysm treatment products, the presence of key manufacturers, and the presence of well-established healthcare and reimbursement facilities in the region are anticipated to propel the intracranial aneurysm market.

For instance, according to data published by the Brain Aneurysm Foundation in the year 2021, an estimated 6.5 million people in the US have an un-ruptured brain aneurysm in the year 2020 and about 30,000 people suffer from a brain aneurysm rupture each year.

Additionally, the rise in government initiatives and funding to support research for brain aneurysms in the country would also increase the regional market for the intracranial aneurysm market. For instance, as per the bill presented in the 117 session on March 03, 2021, USD 10,000,000 has been funded by the government to conduct or support further comprehensive research on unruptured intracranial aneurysms for each of fiscal years 2022 through 2026 which will remain available through September 30, 2029.

Furthermore, strategic business activities and approval of products in the region for the expansion of the intracranial aneurysm market would also boost the regional market. For instance, in the year 2020, Kaneka Corporation received FDA approval for its new brain aneurysm Embolization coil, i-ED COIL™. Further, the company inked an agreement with Asahi Intecc USA. Inc., to expand sales for the device in the US market from August 2021.

Therefore, all the above-mentioned factors will bolster the demand for the intracranial aneurysm market in the region during the forecasted period.

Furthermore, the Asia-pacific region has future potential for the intracranial aneurysm market. This is due to the rising sedentary lifestyle such as consumption of alcohol, increase in aging population, growing head injuries, among others. For instance, as per the World Bank Group 2021 data, in the year 2020, China had 168,863,853 population aged 65 and above.

In addition, rising research and development activities and growing strategic business activity to expand the domestic intracranial aneurysm market in the APAC region would also contribute to the market. For instance, in the year 2021, Zhuhai Tonbridge Medical Tech. Co., Ltd. initiated a clinical trial to study "The Efficacy and Safety Study of Flow Diverter(Ton-bridgeMT) on Endovascular Embolization of Intracranial Aneurysms". The trial is expected to be completed by the year 2023. Thus, all the above-stated factors are likely to contribute to the regional intracranial aneurysm market in the forthcoming years.

Intracranial Aneurysms Market Key Players:

Some of the key market players operating in the Intracranial Aneurysms market include Medtronic, MicroPort Scientific Corporation., B. Braun Melsungen AG, Stryker, Johnson & Johnson Services, Inc., Terumo Corporation, Penumbra, Inc., Balt, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., Mizuho Medical Co.Ltd., Lepu Medical Technology(Beijing)Co., Ltd., Phenox GmbH, Peter LAZIC GmbH, adeor medical AG., Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., KANEKA CORPORATION, and others.

Recent Developmental Activities in the Intracranial Aneurysms Market:

  • In December 2020, Terumo Corporation launched the WEB™ Embolization System (Woven EndoBridge Device), an intrasaccular aneurysm treatment device, in Japan. The WEB device is a first-of-its-kind intrasaccular flow disruptor device available for the Japanese market. With the commercial launch, Terumo will provide new treatment options for brain aneurysm cases.
  • In October 2020, Shanghai MicroPort NeuroTech Co., Ltd. ("MicroPort® NeuroTech") received the registration certificates issued by China's National Medical Products Administration (NMPA) for its proprietary NUMEN Coil Embolization System and NUMEN FR Coil Detachment System for the treatment of cerebral aneurysms through minimally invasive neurovascular intervention.
  • In April 2020, phenox GmbH launched p64 MW Flow Modulation Device with HPC coating technology for the treatment of intracranial aneurysms in the European market. The device received CE mark in January 2020.

Key Takeaways from the Intracranial Aneurysms Market Report Study

  • Market size analysis for current market size (2021), and market forecast for 5 years (2022-2027)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Intracranial Aneurysms market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the Global Intracranial Aneurysms Market.
  • Various opportunities available for the other competitor in the Intracranial Aneurysms Market space.
  • What are the top-performing segments in 2021? How these segments will perform in 2027.
  • Which are the top-performing regions and countries in the current market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Intracranial Aneurysms market growth in the coming future?

Target Audience who can be benefited from the Intracranial Aneurysms Market Report Study

  • Intracranial Aneurysms providers
  • Research organizations and consulting companies
  • Intracranial Aneurysms-related organization, association, forum, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders in Intracranial Aneurysms
  • Various End-users who want to know more about the Intracranial Aneurysms Market and the latest technological developments in the Intracranial Aneurysms market.

Frequently Asked Questions for the Intracranial Aneurysms Market:

1. What are Intracranial Aneurysms?

An intracranial aneurysm or a cerebral aneurysm is an abnormal focal dilation of a brain artery due to the weakening of the inner muscular layer of a blood vessel wall. The vessel develops a "blister-like" dilation that can become thin and rupture without warning.

2. What is the market for Global Intracranial Aneurysms?

The global intracranial aneurysms market was valued at USD 1.13 billion in 2021, growing at a CAGR of 9.10% during the forecast period from 2022 to 2027, to reach USD 1.90 billion by 2027.

3. What are the drivers for the Global Intracranial Aneurysms?

The major factors driving the demand for Intracranial Aneurysms are the increasing prevalence of brain aneurysms and arteriovenous malformations (AVMs) owing to sedentary lifestyles. Moreover, an increase in high blood pressure among the population, approval, and launch of various intracranial aneurysm treatment devices, and rising research and development activities for the development of intracranial aneurysm treatment devices, among others are anticipated to bolster the global intracranial aneurysm market.

4. What are the key players operating in Global Intracranial Aneurysms?

Some of the key market players operating in the Intracranial Aneurysms market include Medtronic, MicroPort Scientific Corporation., B. Braun Melsungen AG, Stryker, Johnson & Johnson Services, Inc., Terumo Corporation, Penumbra, Inc., Balt, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., Mizuho Medical Co.Ltd., Lepu Medical Technology(Beijing)Co., Ltd., Phenox GmbH, Peter LAZIC GmbH, adeor medical AG., Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., KANEKA CORPORATION, and others.

5. Which region has the highest share in the Intracranial Aneurysms market?

Among all the regions, North America is expected to occupy a major share in the overall Intracranial Aneurysms market during the forecasted period. This domination is because of the exponentially rising prevalence of the target population in the region. Furthermore, the recent launch of intracranial aneurysm treatment products, the presence of key manufacturers, and the presence of well-established healthcare and reimbursement facilities in the region are anticipated to propel the intracranial aneurysm market.

Table of Contents

1.Intracranial Aneurysms Market Report Introduction

2.Intracranial Aneurysms Market Executive summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Intracranial Aneurysms Market Key factors analysis

  • 4.1. Intracranial Aneurysms Market Drivers
    • 4.1.1. Rising prevalence of brain aneurysm, and arteriovenous malformations (AVMs) due to severe head injuries, sedentary lifestyle, others
    • 4.1.2. Increase in prevalence of hypertension across the globe
    • 4.1.3. Increasing product approval & launches across the globe
    • 4.1.4. The continuous expansion of the geriatric population
  • 4.2. Intracranial Aneurysms Market Restraints and Challenges
    • 4.2.1. The stringent regulatory approval process
    • 4.2.2. Complications associated with intracranial aneurysm treatment devices
  • 4.3. Intracranial Aneurysms Market Opportunities
    • 4.3.1. Low and middle-income nations have tremendous opportunities for the Intracranial Aneurysms market
    • 4.3.2. Strategic business activities by the global as well as regional manufacturers will provide opportunities in the Intracranial Aneurysms market

5. Intracranial Aneurysms Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Intracranial Aneurysms Market

7. Intracranial Aneurysms Market layout

  • 7.1. By Product Type
    • 7.1.1. Surgical Clippings
    • 7.1.2. Embolization Coils
    • 7.1.3. Flow Diverters
    • 7.1.4. Others
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Ambulatory Surgical Centers
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. North America Intracranial Aneurysms Market, by Product Type
      • 7.3.1.2. North America Intracranial Aneurysms Market, by End User
      • 7.3.1.3. North America Intracranial Aneurysms Market, by Country
      • 7.3.1.3.1. United States
      • 7.3.1.3.2. Canada
      • 7.3.1.3.3. Mexico
    • 7.3.2. Europe
      • 7.3.2.1. Europe Intracranial Aneurysms Market, by Product Type
      • 7.3.2.2. Europe Intracranial Aneurysms Market, by End User
      • 7.3.2.3. Europe Intracranial Aneurysms Market, by Country
      • 7.3.2.3.1. France
      • 7.3.2.3.2. Germany
      • 7.3.2.3.3. United Kingdom
      • 7.3.2.3.4. Italy
      • 7.3.2.3.5. Spain
      • 7.3.2.3.6. Russia
      • 7.3.2.3.7. Rest of Europe
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. Asia-Pacific Intracranial Aneurysms Market, by Product Type
      • 7.3.3.2. Asia-Pacific Intracranial Aneurysms Market, by End User
      • 7.3.3.3. Asia-Pacific Intracranial Aneurysms Market, by Country
      • 7.3.3.3.1. China
      • 7.3.3.3.2. Japan
      • 7.3.3.3.3. India
      • 7.3.3.3.4. Australia
      • 7.3.3.3.5. South Korea
      • 7.3.3.3.6. Rest of Asia Pacific
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. RoW Intracranial Aneurysms Market, by Product Type
      • 7.3.4.2. RoW Intracranial Aneurysms Market, by End User
      • 7.3.4.3. RoW Intracranial Aneurysms Market, by Region
      • 7.3.4.3.1. Middle East
      • 7.3.4.3.2. Africa
      • 7.3.4.3.3. South America

8. Intracranial Aneurysms Global Company Share Analysis - Key 3-5 Companies

9. Intracranial Aneurysms Company and Product Profiles

  • 9.1. Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. MicroPort Scientific Corporation.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. B. Braun Melsungen AG
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Stryker
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Johnson & Johnson Services, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Terumo Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Penumbra, Inc
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Balt
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Wallaby Medical
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Shape Memory Medical Inc
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Zylox-Tonbridge Medical Technology Co., Ltd
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Spartan Micro, Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Mizuho Medical Co.Ltd
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Lepu Medical Technology(Beijing)Co.,Ltd.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Phenox GmbH
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Peter LAZIC GmbH
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. adeor medical AG
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Boston Scientific Corporation
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Meril Life Sciences Pvt. Ltd
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. KANEKA CORPORATION
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Intracranial Aneurysms Market
  • Table 3: Intracranial Aneurysms Market Analysis in Global (2019-2027)
  • Table 4: Intracranial Aneurysms Market Analysis in Global by Product Type (2019-2027)
  • Table 5: Intracranial Aneurysms Market Analysis in Global by End User (2019-2027)
  • Table 6: Intracranial Aneurysms Market Analysis in Global by Geography (2019-2027)
  • Table 7: Intracranial Aneurysms Market Analysis in North America (2019-2027)
  • Table 8: Intracranial Aneurysms Market Analysis in North America by Product Type (2019-2027)
  • Table 9: Intracranial Aneurysms Market Analysis in North America by End User (2019-2027)
  • Table 10: Intracranial Aneurysms Market Analysis in North America by Country (2019-2027)
  • Table 11: Intracranial Aneurysms Market Analysis in the US (2019-2027)
  • Table 12: Intracranial Aneurysms Market Analysis in Canada (2019-2027)
  • Table 13: Intracranial Aneurysms Market Analysis in Mexico (2019-2027)
  • Table 14: Intracranial Aneurysms Market Analysis in Europe (2019-2027)
  • Table 15: Intracranial Aneurysms Market Analysis in Europe by Product Type (2019-2027)
  • Table 16: Intracranial Aneurysms Market Analysis in Europe by End User (2019-2027)
  • Table 17: Intracranial Aneurysms Market Analysis in Europe by Country (2019-2027)
  • Table 18: Intracranial Aneurysms Market Analysis in France (2019-2027)
  • Table 19: Intracranial Aneurysms Market Analysis in Germany (2019-2027)
  • Table 20: Intracranial Aneurysms Market Analysis in the UK (2019-2027)
  • Table 21: Intracranial Aneurysms Market Analysis in Italy (2019-2027)
  • Table 22: Intracranial Aneurysms Market Analysis in Spain (2019-2027)
  • Table 23: Intracranial Aneurysms Market Analysis in Russia (2019-2027)
  • Table 24: Intracranial Aneurysms Market Analysis in Rest of Europe (2019-2027)
  • Table 25: Intracranial Aneurysms Market Analysis in Asia-Pacific (2019-2027)
  • Table 26: Intracranial Aneurysms Market Analysis in Asia-Pacific by Product Type (2019-2027)
  • Table 27: Intracranial Aneurysms Market Analysis in Asia-Pacific by End User (2019-2027)
  • Table 28: Intracranial Aneurysms Market Analysis in Asia-Pacific by Country (2019-2027)
  • Table 29: Intracranial Aneurysms Market Analysis in China (2019-2027)
  • Table 30: Intracranial Aneurysms Market Analysis in Japan (2019-2027)
  • Table 31: Intracranial Aneurysms Market Analysis in India (2019-2027)
  • Table 32: Intracranial Aneurysms Market Analysis in Australia (2019-2027)
  • Table 33: Intracranial Aneurysms Market Analysis in South Korea (2019-2027)
  • Table 34: Intracranial Aneurysms Market Analysis in Rest of Asia-Pacific (2019-2027)
  • Table 35: Intracranial Aneurysms Market Analysis in Rest of World (2019-2027)
  • Table 36: Intracranial Aneurysms Market Analysis in Rest of World by Product Type (2019-2027)
  • Table 37: Intracranial Aneurysms Market Analysis in Rest of World by End User (2019-2027)
  • Table 38: Intracranial Aneurysms Market Analysis in Rest of World by Country (2019-2027)
  • Table 39: Intracranial Aneurysms Market Analysis in the Middle East (2019-2027)
  • Table 40: Intracranial Aneurysms Market Analysis in Africa (2019-2027)
  • Table 41: Intracranial Aneurysms Market Analysis in South America (2019-2027)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Intracranial Aneurysms Market
  • Figure 3: Intracranial Aneurysms Market Analysis in Global (2019-2027)
  • Figure 4: Intracranial Aneurysms Market Analysis in Global by Product Type (2019-2027)
  • Figure 5: Intracranial Aneurysms Market Analysis in Global by End User (2019-2027)
  • Figure 6: Intracranial Aneurysms Market Analysis in Global by Geography (2019-2027)
  • Figure 7: Intracranial Aneurysms Market Analysis in North America (2019-2027)
  • Figure 8: Intracranial Aneurysms Market Analysis in North America by Product Type (2019-2027)
  • Figure 9: Intracranial Aneurysms Market Analysis in North America by End User (2019-2027)
  • Figure 10: Intracranial Aneurysms Market Analysis in North America by Country (2019-2027)
  • Figure 11: Intracranial Aneurysms Market Analysis in the US (2019-2027)
  • Figure 12: Intracranial Aneurysms Market Analysis in Canada (2019-2027)
  • Figure 13: Intracranial Aneurysms Market Analysis in Mexico (2019-2027)
  • Figure 14: Intracranial Aneurysms Market Analysis in Europe (2019-2027)
  • Figure 15: Intracranial Aneurysms Market Analysis in Europe by Product Type (2019-2027)
  • Figure 16: Intracranial Aneurysms Market Analysis in Europe by End User (2019-2027)
  • Figure 17: Intracranial Aneurysms Market Analysis in Europe by Country (2019-2027)
  • Figure 18: Intracranial Aneurysms Market Analysis in France (2019-2027)
  • Figure 19: Intracranial Aneurysms Market Analysis in Germany (2019-2027)
  • Figure 20: Intracranial Aneurysms Market Analysis in the UK (2019-2027)
  • Figure 21: Intracranial Aneurysms Market Analysis in Italy (2019-2027)
  • Figure 22: Intracranial Aneurysms Market Analysis in Spain (2019-2027)
  • Figure 23: Intracranial Aneurysms Market Analysis in Russia (2019-2027)
  • Figure 24: Intracranial Aneurysms Market Analysis in Rest of Europe (2019-2027)
  • Figure 25: Intracranial Aneurysms Market Analysis in Asia-Pacific (2019-2027)
  • Figure 26: Intracranial Aneurysms Market Analysis in Asia-Pacific by Product Type (2019-2027)
  • Figure 27: Intracranial Aneurysms Market Analysis in Asia-Pacific by End User (2019-2027)
  • Figure 28: Intracranial Aneurysms Market Analysis in Asia-Pacific by Country (2019-2027)
  • Figure 29: Intracranial Aneurysms Market Analysis in China (2019-2027)
  • Figure 30: Intracranial Aneurysms Market Analysis in Japan (2019-2027)
  • Figure 31: Intracranial Aneurysms Market Analysis in India (2019-2027)
  • Figure 32: Intracranial Aneurysms Market Analysis in Australia (2019-2027)
  • Figure 33: Intracranial Aneurysms Market Analysis in South Korea (2019-2027)
  • Figure 34: Intracranial Aneurysms Market Analysis in Rest of Asia-Pacific (2019-2027)
  • Figure 35: Intracranial Aneurysms Market Analysis in Rest of World (2019-2027)
  • Figure 36: Intracranial Aneurysms Market Analysis in Rest of World by Product Type (2019-2027)
  • Figure 37: Intracranial Aneurysms Market Analysis in Rest of World by End User (2019-2027)
  • Figure 38: Intracranial Aneurysms Market Analysis in Rest of World by Country (2019-2027)
  • Figure 39: Intracranial Aneurysms Market Analysis in the Middle East (2019-2027)
  • Figure 40: Intracranial Aneurysms Market Analysis in Africa (2019-2027)
  • Figure 41: Intracranial Aneurysms Market Analysis in South America (2019-2027)
  • Figure 42: Market Drivers
  • Figure 43: Market Barriers
  • Figure 44: Market Opportunities
  • Figure 45: PORTER's Five Force Analysis